Suchergebnisse - "Nakashima, Kazutaka"

PubPharm (144)

1

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

enthalten in: Breast cancer | 2024

von Yamamoto, Y. | Yamauchi, C. | Toyama, T. | +14

2

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition : changes from the 2018 edition and general statements on breast cancer treatment

enthalten in: Breast cancer (Tokyo, Japan) | 2024

von Yamamoto, Y. | Yamauchi, C. | Toyama, T. | +14

3

Clinicopathological features of adult T-cell leukemia/lymphoma with T-follicular helper phenotype

enthalten in: Cancer medicine | 2024

von Muto, R. | Miyoshi, H. | Nakashima, K. | +3

4

Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer

enthalten in: Cancer research communications | 2024

von Kinoshita, S. | Ishii, M. | Ando, J. | +11

5

The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition

enthalten in: Breast cancer (Tokyo, Japan) | 2024

von Kubota, K. | Nakashima, K. | Nakashima, K. | +7

ErratumIn: Breast Cancer. 2023 Dec 11;:. - PMID 38079067

6

Correction : The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition

enthalten in: Breast cancer (Tokyo, Japan) | 2024

von Kubota, K. | Nakashima, K. | Nakashima, K. | +8

ErratumFor: Breast Cancer. 2024 Mar;31(2):157-164. - PMID 37973686

7

Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients

enthalten in: Cancer medicine | 2024

von Shimasaki, Y. | Miyoshi, H. | Kawamoto, K. | +18

8

Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma

enthalten in: Pathology, research and practice | 2024

von Mishina, T. | Miyoshi, H. | Takeuchi, M. | +13

9

Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients : CD47 expression is a favourable prognostic factor

enthalten in: Pathology | 2024

von Tanaka, K. | Miyoshi, H. | Kawamoto, K. | +11

10

Clinicopathological comparison between PTCL‐TBX21 and PTCL‐GATA3 in Japanese patients

enthalten in: Cancer Medicine | 2024

von Shimasaki, Y. | Miyoshi, H. | Kawamoto, K. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]